"American dream" in Germany: EKF-diagnostic Group keeps on growing

"American dream" in Germany: EKF-diagnostic Group keeps on growing
(PresseBox) ( Barleben, )
Everybody knows famous stories about big companies, founded in a small garage. But such success stories can also been told in Germany. Especially in the former GDR in 1990, the engineer Berthold Walter launched with a few partners the company EKF. This name consists the first three letters of the German words "Entwicklung, Konstruktion und Fertigung" (development, construction and production). Its main business was focused to industry electronics.

Six years later EKF built their own premises in Barleben close to Magdeburg and was renamed to "EKF-diagnostic GmbH" in 2000 caused by intensified activities in the medical business. Today, with over 120 employees and additional branches, the EKF Group is a leading manufacturer of innovative lab analyzers and medical devices - and the increase of its profit has reached double figures in the past years determined to further expansion.

"We are very well established with our popular device series and we are in act to strengthen the existing market position with additional, own product developments", explains the founder and CEO Berthold Walter. In 2008 this includes an investment about 9 Million EUR for the general enlargement of the company and for the set up of new production line for test strips and HbA1c systems.

With its additional engagement in POC diagnostic EKF created an additional main pillar and will further extend consistently this business. First steps in this market with analyzers for lactate and haemoglobin were very successful, and new technologies as well as innovative design concepts promise good prospects for the future. Therefore, the long-term product development shall be combined with a conclusion of the EKF-Group to a holding, as announced by Berthold Walter: "Speaking with investors during the next months, we're looking forward to company's transit to a PLC, checking options for an initial public offer (IPO) in three or four years latest. It's our target to be one of the market leaders in POC diagnostics not only in Europe but worldwide."
Für die oben stehenden Pressemitteilungen, das angezeigte Event bzw. das Stellenangebot sowie für das angezeigte Bild- und Tonmaterial ist allein der jeweils angegebene Herausgeber (siehe Firmeninfo bei Klick auf Bild/Meldungstitel oder Firmeninfo rechte Spalte) verantwortlich. Dieser ist in der Regel auch Urheber der Pressetexte sowie der angehängten Bild-, Ton- und Informationsmaterialien.
Die Nutzung von hier veröffentlichten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Bei Veröffentlichung senden Sie bitte ein Belegexemplar an service@pressebox.de.